arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

QUEST DIAGNOSTICS INC

DGX
$238.30 ▼ -0.27 (-0.11%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
20 Visible periods
33 Metrics
Peer-ranked Benchmarks
Price Chart
68
Health
Good
Bullish
auto_awesome

Analytical Summary

QUEST DIAGNOSTICS INC shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $26.5B
Dividend Yield
Revenue Growth 11.8%
Op. Margin 14.1%
ROIC 9.6%
FCF / Share $12.24
Trailing P/E 26.9x
Price / Book 3.7x
FCF Yield 5.1%
Debt / Equity 0.79
info Valuation on last close. End-of-day price, Aug 7, 2026.

20-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$11.04B
↑ +11.8%
Net Income Profit after all expenses
$992.00M
↑ +13.9%
Operating Margin Operating profit as % of sales
14.1%
↑ +3.4% 65th
FCF / Share Free cash flow per share
$12.24
↑ +49.5%
Long-Term Debt Long-term obligations
$5.67B
↓ -8.8%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
65
Returns
78
Financial Health
55
Cash Quality
78

Dividend History

Dividend / share · sourced from SEC filings
$1.80 Latest / share
+9.1% YoY
+10.9% 4-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 20 years · 75 quarters